Dolor Therapeutics, Inc.
Chicago, IL Doing business as Dolor Therapeutics LLC
- UEI
- CPVTJJJHGE45
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3410 N Lawndale Ave #3, Chicago, IL 60618, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| From formulation to IND: optimization of a dual cromolyn-cetirizine enteric softgel for chronic prostatitis/chronic… | National Institute of Diabetes and Digestive and Kidney Diseases | $1,124,999 | |
| Optimizing dual therapy for chronic prostatitis/chronic pelvic pain syndrome - summary chronic prostatitis/chronic… | National Institute of Diabetes and Digestive and Kidney Diseases | $318,488 |
Quick answers
What is Dolor Therapeutics, Inc.'s UEI?
Dolor Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is CPVTJJJHGE45.
Where is Dolor Therapeutics, Inc. located?
Dolor Therapeutics, Inc.'s physical address in SAM.gov is 3410 N Lawndale Ave #3, Chicago, IL 60618, USA.
Is Dolor Therapeutics, Inc. registered in SAM.gov?
Yes. Dolor Therapeutics, Inc.'s SAM.gov registration is active through July 24, 2027.
What is Dolor Therapeutics, Inc.'s most recent federal award?
Dolor Therapeutics, Inc.'s most recent federal grant award is From formulation to IND: optimization of a dual cromolyn-cetirizine enteric softgel for chronic prostatitis/chronic… (R44DK139835), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 1, 2024.
On GovTribe
See Dolor Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors